Evidence map›Paper›PMID 34006022›Full record

ArticleBMJ open2021

Protocol for an interdisciplinary cross-sectional study investigating the social, biological and community-level drivers of antimicrobial resistance (AMR): Holistic Approach to Unravel Antibacterial Resistance in East Africa (HATUA).

Benon B Asiimwe, John Kiiru, Stephen E Mshana, Stella Neema, Katherine Keenan, Mike Kesby, Joseph R Mwanga, Derek J Sloan, Blandina T Mmbaga, V Anne Smith and 10 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 5 countries.

Benon B Asiimwe *School of Biomedical Sciences, Makerere University, Kampala, Uganda.
John Kiiru *Centre for Microbiology Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Stephen E Mshana *Department of Microbiology and Immunology, Catholic University of Health and Allied Sciences, Mwanza, Tanzania.
Stella NeemaCollege of Humanities and Social Science, Makerere University, Kampala, Uganda.
Katherine KeenanGeography and Sustainable Development, University of St Andrews, St Andrews, Fife, UK katherine.keenan@st-andrews.ac.uk.ORCID 0000-0002-9670-1607
Mike KesbyGeography and Sustainable Development, University of St Andrews, St Andrews, Fife, UK.
Joseph R MwangaSchool of Public Health, Catholic University of Health and Allied Sciences, Mwanza, Tanzania.
Derek J SloanSchool of Medicine, University of St Andrews, St Andrews, UK.
Blandina T MmbagaKilimanjaro Clinical Research Institute, Kilimanjaro Christian Medical Centre and Kilimanjaro Christian Medical University College, Moshi, Tanzania.
V Anne SmithSchool of Biology, University of St Andrews, St Andrews, UK.
Stephen H GillespieSchool of Medicine, University of St Andrews, St Andrews, UK.
Andy G LynchSchool of Medicine, University of St Andrews, St Andrews, UK.
Alison SandemanSchool of Medicine, University of St Andrews, St Andrews, UK.
John StellingDepartment of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Alison ElliottClinical Research Department, London School of Hygiene & Tropical Medicine, London, UK.ORCID 0000-0003-2818-9549
David M AanensenCentre for Genomic Pathogen Surveillance, Wellcome Genome Campus, Cambridge, UK.
Gibson E KibikiEast African Health Research Commission, Bujumbura, Burundi.
Wilber SabiitiSchool of Medicine, University of St Andrews, St Andrews, UK.
Matthew T G HoldenSchool of Medicine, University of St Andrews, St Andrews, UK.
HATUA Consortium
University of St Andrews · GBCatholic University of Health and Allied Sciences · TZMakerere University · UGBrigham and Women's Hospital · USKenya Medical Research Institute · KEKilimanjaro Christian Medical Centre · TZLondon School of Hygiene & Tropical Medicine · GBUniversity of Oxford · GB

Funding

Integrating the world's microbiology laboratories into a global microbial surveillance systemU01CA207167 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI STELLING, JOHN · 2016 to 2018
$1.3M
Medical Research Council 107743Medical Research Council MC_UU_00027/5Medical Research Council MR/S004785/1NCI NIH HHS U01 CA207167Wellcome TrustWellcome Trust 107743
6 · The paper itself

Abstract

introductionAntimicrobial resistance (AMR) is a global health threat that requires urgent research using a multidisciplinary approach. The biological drivers of AMR are well understood, but factors related to treatment seeking and the social contexts of antibiotic (AB) use behaviours are less understood. Here we describe the Holistic Approach to Unravel Antibacterial Resistance in East Africa, a multicentre consortium that investigates the diverse drivers of drug resistance in urinary tract infections (UTIs) in East Africa. METHODS AND ANALYSIS: This study will take place in Uganda, Kenya and Tanzania. We will conduct geospatial mapping of AB sellers, and conduct mystery client studies and in-depth interviews (IDIs) with drug sellers to investigate AB provision practices. In parallel, we will conduct IDIs with doctors, alongside community focus groups. Clinically diagnosed patients with UTI will be recruited from healthcare centres, provide urine samples and complete a questionnaire capturing retrospective treatment pathways, sociodemographic characteristics, attitudes and knowledge. Bacterial isolates from urine and stool samples will be subject to culture and antibiotic sensitivity testing. Genomic DNA from bacterial isolates will be extracted with a subset being sequenced. A follow-up household interview will be conducted with 1800 UTI-positive patients, where further environmental samples will be collected. A subsample of patients will be interviewed using qualitative tools. Questionnaire data, microbiological analysis and qualitative data will be linked at the individual level. Quantitative data will be analysed using statistical modelling, including Bayesian network analysis, and all forms of qualitative data analysed through iterative thematic content analysis. ETHICS AND DISSEMINATION: Approvals have been obtained from all national and local ethical review bodies in East Africa and the UK. Results will be disseminated in communities, with local and global policy stakeholders, and in academic circles. They will have great potential to inform policy, improve clinical practice and build regional pathogen surveillance capacity.

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialBayes TheoremCross-Sectional StudiesHumansKenyaRetrospective StudiesTanzaniaUgandaAnti-Bacterial Agentsinfection controlmicrobiologypublic healthsocial medicineurinary tract infections

Identifiers

PMID34006022
PMCPMC7942251
OpenAlexW3135024082

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.